(Q44022301)
Statements
1 reference
A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population (English)
1 reference
J I Clark
1 reference
T M Kuzel
1 reference
T M Lestingi
1 reference
S G Fisher
1 reference
P Sorokin
1 reference
B Martone
1 reference
M Viola
1 reference
J A Sosman
1 reference
1 April 2002
1 reference
1 reference
13
1 reference
4
1 reference
606-613
1 reference
Identifiers
1 reference
1 reference